|
KIF13A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.340740E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.199400E-01 |
| Normal-vs-Stage2 |
6.601000E-03 |
| Normal-vs-Stage3 |
1.98572999999813E-05 |
| Normal-vs-Stage4 |
2.95989999954394E-07 |
| Stage1-vs-Stage2 |
1.272090E-02 |
| Stage1-vs-Stage3 |
4.04000000000515E-05 |
| Stage1-vs-Stage4 |
1.08750000005209E-06 |
| Stage2-vs-Stage3 |
6.217600E-01 |
| Stage2-vs-Stage4 |
1.684830E-01 |
| Stage3-vs-Stage4 |
2.606200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.137700E-03 |
| Normal-vs-AfricanAmerican |
7.818300E-03 |
| Normal-vs-Asian |
8.602200E-01 |
| Caucasian-vs-AfricanAmerican |
3.393800E-01 |
| Caucasian-vs-Asian |
2.860000E-01 |
| AfricanAmerican-vs-Asian |
1.982210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.164600E-04 |
| Normal-vs-Female |
4.175600E-02 |
| Male-vs-Female |
1.648210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.484630E-01 |
| Normal-vs-Age(41-60Yrs) |
7.491800E-02 |
| Normal-vs-Age(61-80Yrs) |
2.224000E-04 |
| Normal-vs-Age(81-100Yrs) |
6.020600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.636400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.403400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.562200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.645900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.527900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.135200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.159670E-02 |
| Normal-vs-Grade 2 |
4.487600E-01 |
| Normal-vs-Grade 3 |
4.36409999999832E-05 |
| Normal-vs-Grade 4 |
1.77129999556769E-09 |
| Grade 1-vs-Grade 2 |
2.315600E-02 |
| Grade 1-vs-Grade 3 |
1.157340E-04 |
| Grade 1-vs-Grade 4 |
2.34930000009292E-07 |
| Grade 2-vs-Grade 3 |
1.550680E-04 |
| Grade 2-vs-Grade 4 |
1.86559999670877E-08 |
| Grade 3-vs-Grade 4 |
1.964170E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.406000E-01 |
| Normal-vs-ccB subtype |
2.37089999999274E-05 |
| ccA subtype-vs-ccB subtype |
1.09959999994302E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.139100E-03 |
| Normal-vs-N1 |
1.884320E-02 |
| N0-vs-N1 |
1.496780E-01 |
|
|
